Fundación Oftalmológica de Santander Carlos Ardila Lule

Floridablanca, Santander Department 681004

0 studies enrolling now · 2 studies all time

What they study most

Cancer, Solid Tumors Harboring NTRK Fusion

Studies at this site

• Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer — Running, not enrolling
• A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors — Completed